Enhancing Cancer Prevention and Control Pathways-Native Health Initiative (NCT04259762) | Clinical Trial Compass
CompletedNot Applicable
Enhancing Cancer Prevention and Control Pathways-Native Health Initiative
United States508 participantsStarted 2021-06-01
Plain-language summary
There are continued disparities in cancer incidence, mortality, and survival between American Indians (AIs) and Whites on cancers responsive to early screening (i.e., breast, colorectal, and cervical) in the US. In New Mexico (NM), AIs compared with other racial/ethnic populations are significantly less likely to adhere to recommended screening guidelines. The purpose of this trial is to develop and pilot test multilevel/multicomponent intervention strategies to enhance screening for breast, colorectal, and cervical cancers.
Who can participate
Age range
21 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria: Breast Cancer Screening Intervention
* Women age 45-75
* Average risk for breast cancer
* Never had a mammogram OR not had a mammogram within the past 2 years
* Residing in the Zuni Pueblo
Exclusion Criteria: Breast Cancer Screening Intervention. Meeting at least one of the following criteria:
* Women with breast implants, pregnant, or breast feeding
* History of breast cancer
* Have new breast complaints such as lump or nipple discharge
Inclusion Criteria: Colorectal Cancer Screening Intervention
* Men and women aged 45-75
* Average risk for colorectal cancer
* Never had a fecal occult blood test (FOBT), or fecal immunochemical test (FIT) or a colonoscopy OR not had a FOBT or FIT in the past year, OR no colonoscopy in the past 10 years
* Residing in the Zuni Pueblo
Exclusion Criteria: Colorectal Cancer Screening Intervention. Meeting at least one of the following criteria:
* History of colorectal cancer, total colectomy, adenomatous polyps, or inflammatory bowel disease
* Up-to-date with colorectal cancer screening
* Severe comorbidity
* Incarceration
* Family history of colorectal cancer
* Hospice/terminal care status
Inclusion Criteria: Cervical Cancer Screening Intervention
* Women aged 21-65
* Never had a cytology (Pap smear) OR had a Pap smear more than 3 years ago OR women aged 30-75, and never had screening with a combination of cytology and human papillomavirus testing OR no combination of testing in the past 5 years
* Residing in the Zun…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Aim 3, Focus Groups, Descriptive: Knowledge, Barriers and Support, and Communication About Breast, Cervix, and Colorectal Cancers
Timeframe: 12 months
2
Aim 4, Community Survey, Descriptive: Cancer Control Needs
Timeframe: 7 months
3
Aim 8, INT, Pilot Test: Age/Gender-specific Breast, Colorectal, and Cervical Cancer Screening